Kevin Parker is the CEO and Co-Founder of Cartography Biosciences. Kevin completed his PhD at Standford working in the interface of genomics, immunology, and computational biology. He holds a BA in Human Development and Regenerative Biology from Harvard University, Kevin has co-authored papers in journals such as Cell and Science directed at understanding immunotherapy responses, analyzing antigen profiles, and developing novel single-cell genomics methodologies. At Cartography, he is motivated to improve patient outcomes and bring new therapies to patients, and outside of Cartography, Kevin is an avid rock climber.
Kevin Parker, PhD